Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On

October 26, 2020
In this May 2020 file photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Monday, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn

The trial studied the efficacy of bamlanivimab and remdesivir on hospitalized COVID-19 patients - the same therapies given to President Trump. But researchers say people showed no marked improvement.

(Image credit: David Morrison/AP)



from News : NPR https://ift.tt/3kyGSqO

Leave a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.